Progress with pancreatic cancer can be obtained by focusing on these major issues

Problems in General Surgery

Volumn 14, Issue 2, 1997, Pages 33-42

  Moonka, Ravi ^a   Bell Jr , Richard H ^b  

^a Surgical Service (112)   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RECURRENCE; CANCER SCREENING; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; EARLY DIAGNOSIS; HUMAN; LYMPH NODE METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

EID: 0030663845     PISSN: 07398328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Allema JH, Reinders ME, Van Gulik TM, et al. Prognostic factors for survival after pancreaticoduodenectomy for carcinoma of the pancreatic head region. Cancer 1995;74:2069-76.
2. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994;192:79-86.
3. Bluemke DA, Cameron JL, Hruban RH. Potentially resectable pancreatic adenocarcinoma: spiral CT with surgical and pathological correlation. Radiology 1995;197:381-5.
4. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics 1994. CA Cancer J Clin 1994;44:7-26.
5. Chang KJ, Katz KD, Durbin TE, et al. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc 1994;40:694-9.
6. Coia L, Hoffman J, Scher R. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 1994;30:161-7.
7. Connolly MM, Dawson PJ, Michelassi F, Moossa AR, Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987;206:366-73.
8. Cubilla A, Fortner J, Fitzgerald PJ. Lymph node involvement in carcinoma of the head of the pancreas area. Cancer 1978;41:880-7.
9. DiGiuseppe JA, Hruban RH, Offerhaus GJA, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994;144: 889-95.
10. DiMagno EP. Preoperative staging of pancreatic cancer in the USA [Abstract]. Int J Pancreatol 1994;16:112-4.
11. Douglass HO, Penetrante RB. Pancreatic cancer: why patients die. Int J Pancreatol 1990;7:135-9.
12. Douglass HO, Stablein DM. Ten year follow-up of the first generation surgical adjuvant studies of the GITSG. In: Salmon SE, ed. Adjuvant therapy of cancer VI. Philadelphia: Saunders, 1990:405-15.
13. Ekbom A, McLaughlin J, Karlsson BM, et al. Pancreatitis and pancreatic cancer: a population based study. JNCI 1994;86:625-7.
14. Es JM, Polak MM, Berg FM, et al. Molecular markers for diagnostic cytology of neoplasms in the head of the pancreas: mutation of K-ras and overexpression of the p53 product. J Clin Pathol 95;48:218-22.
15. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127: 1335-9.
16. Evans JP, Burke W, Chen R, et al. Familial pancreatic adenocarcinoma: an association with diabetes and early molecular diagnosis. J Med Genet 1995;32:330-5.
17. Fortner JG. Regional pancreatectomy for cancer of the pancreas, ampulla and other related sites: tumor staging and results. Ann Surg 1984;186:418-25.
18. Fortner JG, King DG, Cubilla A, Turnbill A, Pahnke L, Shils M. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 1977;186:42-50.
19. Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 1996; 223:147-53.
20. Freeny PC, Marks WM, Ryan JA, Traverso W. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology 1988;166:125-33.
21. Freeny P, Traverso W, Ryan J. Diagnosis and staging of pancreatic adenocarcinoma with dynamic CT. Am J Surg 1993;165:600-6.
22. 18F-fluoro-2-deoxy-D-glucose positron emission tomography. Gut 1995;36:771-7.
23. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein excision in the treatment of pancreatic adenocarcinoma adherent to the superior mesentericportal vein confluence. Ann Surg 1996;223:154-62.
24. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-10.
25. Geer R, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-73.
26. Gold EB. Epidemiology and risk factors for pancreatic cancer. Surg Clin North Am 1995;75:819-43.
27. Gothoff A, Rothe B, Klapdor R, Kloppel G, Greten H. Site of recurrence after resection for pancreatic cancer [Abstract]. Dig Dis Sci 1987;32:1168.
28. Griffin JF, Smalley SR, Jewell W. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56-61.
29. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284-303.
30. Henne-Bruns D, Kremer B, Meyer-Pannwitt U, Vogel I, Schroder S. Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: initial results. Hepatogastroenterology 1993;40:145-9.
31. Ishikawa O, Ohigashi H, Imaoka S, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992;215:231-6.
32. Ishikawa O, Ohigashi H, Imaoka S, et al. Is the longterm survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg 1994;129:1075-80.
33. Jessup JM, Steele G, Mayer RJ, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993;128:559-64.
34. Johnstone P, Sindelar WF. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial. Int J Radiat Oncol Biol Phys 1993;27:831-4.
35. Kaiser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
36. Kayahara M, Nagakawa T, Konishi I, Ueno K, Ohta T, Miyazaki I. Clinicopathologic study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 1991;10:105-11.
37. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72:2118-23.
38. Kessler H. Cancer mortality among diabetics. JNCl 1970;44:673-86.
39. Knight K, Fielding JE, Battista RN. Occult blood screening for colorectal cancer. JAMA 1989;261:587-93.
40. Kobari M, Sunamura M, Ohashi O, Saitoh Y, Yusa T, Matsuno S. Usefulness of Japanese staging in the prognosis of patients treated operatively for adenocarcinoma of the head of the pancreas. J Am Coll Surg 1996;182:24-32.
41. Lowenfels AB, Maisonneuve P, Cavillani G, et al. Pancreatitis and pancreatic cancer. N Engl J Med 1993;328:1485-6.
42. Lynch HT. Genetics and pancreatitic cancer. Arch Surg 1994;129:266-8.
43. Manabe T, Ohshio G, Baba N, Tobe T. Factors influencing prognosis and indications for curative pancreatectomy for ductal adenocarcinoma of the head of the pancreas. Int J Pancreatol 1990;7:187-93.
44. Mant D, Fowler G. Mass screening: theory and ethics. B Med J 1990;300:916-8.
45. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability-report of the Radiology Diagnostic Oncology Group. Radiology 1995;195:327-32.
46. Moossa AR, Levin B. The diagnosis of "early" pancreatic cancer. Cancer 1981;47:1688-97.
47. Nagakawa T, Konishi I, Ueno K. Surgical treatment of pancreatic cancer: the Japanese experience. Int J Pancreatol 1991;9:135-43.
48. Nitecki S, Garr MG, Colby TV, Heerden JA. Longterm survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Ann Surg 1995;221: 59-66.
49. Noy A, Bilezikian J. Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab 1994;79:1223-31.
50. Ohta T, Nagakawa T, Ueno K, et al. The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size. Int Surg 1993;78:208-12.
51. Pasquali C, Sperti A, D'Andrea A, et al. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer. Pancreas 1987;2:34-7.
52. Perdue P, Page D, Nellestein M, Salem C, Galbo C, Ghosh B. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions. Surgery 1992;111:656-9.
53. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 1980;46:1945-9.
54. Podolsky DK. Serologic markers in the diagnosis and management of pancreatic carcinoma. World J Surg 1984;8:822-30.
55. Reber H, Ashley SW, McFadden D. Curative treatment for pancreatic neoplasms: radical resection. Surg Clin North Am 1995;75:905-12.
56. Rosch T, Braig C, Gain T, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography: comparison with conventional sonography, computerized tomography, and angiography. Gastroenterology 1992;102:188-99.
57. Safi F, Roscher R, Bittner R, Schenkluhn B, Dopfer HP, Beger HG. High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings. Pancreas 1987;2:398-403.
58. Satake K. Diagnosis of pancreatic cancer; serologic markers. Int J Pancreatol 1991;9:93-8.
59. Satake K, Nishiwaki H, Yokomatsu H, et al. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 1992;175:259-65.
60. Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989;124:127-32.
61. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990;85:350-5.
62. Steinberg WS, Gelfand R, Anderson KK, et al. Comparison of the sensitivity and specificity of the CA 19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986;90:343-9.
63. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996; 110:227-31.
64. Tada M, Omata M, Kawai S, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
65. Talamini G, Falconi M, Bassi C, et al. Incidence of malignant neoplasms in the course of chronic pancreatitis [Abstract]. Gastroenterology 1996;110(suppl): A435.
66. Tan HP, Smith J, Garberoglio CA. Pancreatic adenocarcinoma: an update. J Am Coll Surg 1996;183:164-84.
67. Tashiro S, Uchino R, Hiraoka T, et al. Surgical indication and significance of portal vein resection in biliary and pancreatic cancer. Surgery 1991;109:481-7.
68. Tatasuta M, Yamamura H, Iishi H, et al. Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor. Cancer 1985;56:2669-373.
69. Trede M, Schwall G, Saeger H. Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-58.
70. Tsuchiya R, Oribe T, Noda T. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am J Gastroenterol 1985; 80:459-62.
71. Warshaw AL, Swanson RS. Pancreatic cancer in 1988: possibilities and probabilities. Ann Surg 1988;208: 541-53.
72. Westerdahl J, Andren-Sandeberg A, Ihse I. Recurrence of exocrine pancreatic cancer - local or hepatic? Hepatogastroenterology 1993;40:384-7.
73. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas: implications for radiation therapy. Ann Surg 1993;217:144-8.
74. Wittenberg J, Ferrucci JT, Warshaw AL. Contribution of CT to patients with pancreatic adenocarcinoma. World J Surg 1984;8:831-8.
75. Yasuda K, Mukai H, Nakajima M. Endoscopic ultrasonographic diagnosis of pancreatic cancer. Gastrointest Endosc Clin North Am 1995;5:735-9.
76. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-33.